169 related articles for article (PubMed ID: 35977671)
1. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ
Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671
[TBL] [Abstract][Full Text] [Related]
2. Value of
Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
[TBL] [Abstract][Full Text] [Related]
3. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
4. Relationship between 18F-FDG PET/CT radiometabolic markers and EGFR mutation, positive ALK Expression in patients with non-small cell lung cancer.
Gayaf M; Anar C; Aksel N; Erbaycu AE; Koporal H
Tuberk Toraks; 2021 Dec; 69(4):437-448. PubMed ID: 34957737
[TBL] [Abstract][Full Text] [Related]
5. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J
Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026
[TBL] [Abstract][Full Text] [Related]
6. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
7. Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
Ruan D; Fang J; Teng X
Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):70-83. PubMed ID: 35420272
[TBL] [Abstract][Full Text] [Related]
8. Predicting EGFR mutation subtypes in lung adenocarcinoma using
Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
[TBL] [Abstract][Full Text] [Related]
9. Machine learning approach using 18 F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
Agüloğlu N; Aksu A; Unat DS
Nucl Med Commun; 2023 Apr; 44(4):302-308. PubMed ID: 36756766
[TBL] [Abstract][Full Text] [Related]
10. CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer.
Agazzi GM; Ravanelli M; Roca E; Medicina D; Balzarini P; Pessina C; Vermi W; Berruti A; Maroldi R; Farina D
Radiol Med; 2021 Jun; 126(6):786-794. PubMed ID: 33512651
[TBL] [Abstract][Full Text] [Related]
11. Correlation between combining
Ruan M; Liu L; Wang L; Lei B; Sun X; Chang C; Shen Y; Xie W
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1183-1197. PubMed ID: 31897590
[TBL] [Abstract][Full Text] [Related]
12. Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study.
Tan X; Li Y; Wang S; Xia H; Meng R; Xu J; Duan Y; Li Y; Yang G; Ma Y; Jin Y
Respir Res; 2022 May; 23(1):132. PubMed ID: 35624472
[TBL] [Abstract][Full Text] [Related]
13. The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer.
Liu A; Han A; Zhu H; Ma L; Huang Y; Li M; Jin F; Yang Q; Yu J
Oncotarget; 2017 May; 8(20):33736-33744. PubMed ID: 28422710
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on
Koyasu S; Nishio M; Isoda H; Nakamoto Y; Togashi K
Ann Nucl Med; 2020 Jan; 34(1):49-57. PubMed ID: 31659591
[TBL] [Abstract][Full Text] [Related]
15. Volumetric and radiomics assessment of lesions with incidental [18F]FDG uptake in the colon: a retrospective radiomics study.
Agüloğlu N; Acar Akkaya E; Binicier ÖB
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):145-151. PubMed ID: 34664824
[TBL] [Abstract][Full Text] [Related]
16. Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.
Abdurixiti M; Nijiati M; Shen R; Ya Q; Abuduxiku N; Nijiati M
Br J Radiol; 2021 Jun; 94(1122):20201272. PubMed ID: 33882244
[TBL] [Abstract][Full Text] [Related]
17. [Semiquantitative parameters of
Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
[TBL] [Abstract][Full Text] [Related]
18. Application of 18 F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy.
Park SB; Kim KU; Park YW; Hwang JH; Lim CH
Nucl Med Commun; 2023 Feb; 44(2):161-168. PubMed ID: 36458424
[TBL] [Abstract][Full Text] [Related]
19. Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.
Caicedo C; Garcia-Velloso MJ; Lozano MD; Labiano T; Vigil Diaz C; Lopez-Picazo JM; Gurpide A; Zulueta JJ; Richter Echevarria JA; Perez Gracia JL
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2058-65. PubMed ID: 24990403
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer.
Guan J; Xiao NJ; Chen M; Zhou WL; Zhang YW; Wang S; Dai YM; Li L; Zhang Y; Li QY; Li XZ; Yang M; Wu HB; Chen LH; Liu LY
Medicine (Baltimore); 2016 Jul; 95(30):e4421. PubMed ID: 27472739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]